Kriya Announces $150 Million Addition To Its Series C, Bringing Total Round To Over $430 Million To Further Its Mission Of Delivering Gene Therapies For Prevalent Diseases
Round Type
Series C
MorrisvilleBiotechnologyresearchDescription
Kriya Therapeutics, Inc., a biopharmaceutical company developing gene therapies for conditions affecting millions of people around the world, today announced the addition of over $150 million in capital committed as part of its Series C Financing, bringing the total Series C round to over $430 million. Proceeds from the financing will support the clinical translation of Kriya’s broad pipeline of gene therapies and continued scaling of its engineering, computational and manufacturing platforms. Since its founding in October 2019, Kriya has raised over $600 million in committed capital —and with this financing, Kriya’s cash runway is anticipated to run into late 2026.
Who else raised in research and Biotechnology around the same time
Companies in the same sectors as Kriya Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Aptose Biosciences raised $3M (Seed) on September 6, 2023.
- QuantHealth raised $15M (Series A) on August 31, 2023.
- Epigenic Therapeutics raised $32M (Series A) on August 30, 2023.
- ProMIS Neurosciences raised $20M (Post-IPO Equity) on September 8, 2023.
- Grit Biotechnology raised $60M (Series B) on September 8, 2023.
- Porosome Therapeutics raised $2.5M (Seed) on September 8, 2023.
Who to call at Kriya Therapeutics, and when
A new round usually means Kriya Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kriya Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kriya Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kriya Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kriya Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Kriya Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.